As of Sep 29, 2024, Biomx's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.

The Biomx P/S history

Biomx Aktienanalyse

What does Biomx do?

Biomx Inc is a biotech company specializing in the development of bacterial therapies for the treatment of neurological and metabolic disorders. The company was founded in 2015 in Israel and has since moved its headquarters to San Francisco. Biomx's business model is based on the discovery, isolation, and characterization of bacterial strains associated with specific diseases, and the development of therapies that can target and eliminate these bacteria. The company employs a combination of cutting-edge genomic, proteomic, and bioinformatic technologies to identify and analyze new bacterial species and strains. Biomx has two main areas of focus. The first is the development of bacteriophages (viruses that infect and destroy bacteria) that specifically target certain bacterial species associated with particular diseases. This includes the Colorectal Cancer program, which aims to develop bacterial therapies for the treatment of colon cancer. The second area is the development of bacterial therapies targeting specific pathogens. One potential therapy that could be developed in the future, for example, is one that targets the bacterium Helicobacter pylori, which can cause stomach ulcers and stomach cancer. Biomx has also formed partnerships with other leading biopharmaceutical companies to utilize its technology platforms and develop bacterial therapies. Biomx has several promising products in its pipeline, including BX002, a bacteriophage product for the treatment of acute diarrhea caused by Clostridium difficile, CX002, a bacterial product for the treatment of acute respiratory failure, and a program for the development of bacterial therapies for the treatment of Crohn's disease. Overall, Biomx has played a significant role in the development of new methods for disease treatment in recent years and is expected to continue to be a key player in the biotechnology industry in the future. Biomx ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Biomx's P/S Ratio

Biomx's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Biomx's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Biomx's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Biomx’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Biomx stock

What is the price-to-earnings ratio of Biomx?

The price-earnings ratio of Biomx is currently 0.

How has the price-earnings ratio of Biomx changed compared to last year?

The price-to-earnings ratio of Biomx has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Biomx high compared to other companies?

Yes, the price-to-earnings ratio of Biomx is high compared to other companies.

How does an increase in the price-earnings ratio of Biomx affect the company?

An increase in the price-earnings ratio of Biomx would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Biomx affect the company?

A decrease in the price-earnings ratio of Biomx would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Biomx?

Some factors that influence the price-earnings ratio of Biomx are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Biomx pay?

Over the past 12 months, Biomx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biomx is expected to pay a dividend of 0 USD.

What is the dividend yield of Biomx?

The current dividend yield of Biomx is .

When does Biomx pay dividends?

Biomx pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biomx?

Biomx paid dividends every year for the past 0 years.

What is the dividend of Biomx?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biomx located?

Biomx is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biomx kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biomx from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Biomx pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Biomx in the year 2023?

In the year 2023, Biomx distributed 0 USD as dividends.

In which currency does Biomx pay out the dividend?

The dividends of Biomx are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Biomx

Our stock analysis for Biomx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biomx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.